Related Experiment Video
Updated: Sep 14, 2025

Author Spotlight: Combining Proximity Ligand Assay with Gamma-H2AX Staining to Characterize Protein Interactions in DNA Damage Response
Published on: August 2, 2024
Krüppel-like Factor 4-Deficient Cells Are Sensitive to Etoposide-Induced DNA Damage
Maxwell H Rubinstein1, Aidan Conroy1,2, Elisabeth L Pezzuto1,3
1Department of Biology, Colgate University, Hamilton, NY 13346, USA.
Abstract:
Krüppel-like factor 4 (KLF4) is a highly conserved zinc-finger transcription factor involved in cellular processes such as development, differentiation, and cell cycle regulation. Previous studies show that mouse embryonic fibroblasts (MEFs) null for Klf4 exhibit increased genomic instability. While KLF4 is regarded as a tumor suppressor in many human cancers, its role in DNA repair mechanisms remains unknown. In this study, cultured MEFs wild type (+/+) and null (-/-) for Klf4 and human carcinoma colorectal (RKO) cells were studied as a model for human colorectal cancer. Etoposide, a chemotherapeutic topoisomerase II poison, was employed to investigate KLF4's role in DNA damage repair. Following etoposide treatment, immunostaining and Western blotting revealed cells expressing Klf4 exhibited lower levels of γ-H2AX, a biomarker for DNA damage, compared to cells without Klf4. Moreover, after DNA damage, cells expressing Klf4 exhibited increased levels of BRCA1 and Rad51, known tumor suppressor genes. Finally, genes involved in DNA damage response (DDR), ATR, and Chk1 were upregulated in cells containing functional KLF4, offering a possible mechanism for KLF4's role in mediating DDR. Our results indicate that KLF4 plays a crucial role in maintaining genetic stability by enhancing cell DDR, supporting previous findings that KLF4 functions as a tumor suppressor.
Insights
Krüppel-like factor 4 (KLF4) enhances DNA damage repair and maintains genetic stability. This transcription factor upregulates DNA damage response genes, supporting its role as a tumor suppressor.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Krüppel-like factor 4 (KLF4) is a transcription factor vital for cellular processes.
- KLF4 deficiency in mouse embryonic fibroblasts (MEFs) leads to genomic instability.
- KLF4 is recognized as a tumor suppressor, but its role in DNA repair is unclear.
Purpose of the Study:
- To investigate the role of KLF4 in DNA damage repair mechanisms.
- To elucidate KLF4's function in maintaining genetic stability.
- To explore KLF4's involvement in the DNA damage response (DDR) pathway.
Main Methods:
- Cultured wild type and KLF4-null MEFs and human colorectal cancer cells (RKO).
- Treatment with etoposide, a topoisomerase II inhibitor, to induce DNA damage.
- Immunostaining, Western blotting, and gene expression analysis to assess DNA damage and repair markers.
Main Results:
- Cells expressing KLF4 showed reduced levels of γ-H2AX (a DNA damage biomarker) after etoposide treatment.
- KLF4-expressing cells exhibited increased levels of BRCA1 and Rad51 following DNA damage.
- Genes in the DDR pathway, including ATR and Chk1, were upregulated in cells with functional KLF4.
Conclusions:
- KLF4 plays a critical role in enhancing cellular DNA damage response (DDR).
- KLF4 contributes to maintaining genetic stability by promoting efficient DNA repair.
- These findings reinforce KLF4's function as a tumor suppressor in the context of DNA repair.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Negative Regulator Molecules
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
Treatment Resistant Cancers

